These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 16932617)
41. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829 [TBL] [Abstract][Full Text] [Related]
42. Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis? Kavanaugh A Nat Clin Pract Rheumatol; 2006 Jul; 2(7):346-7. PubMed ID: 16932716 [No Abstract] [Full Text] [Related]
43. [The time for gold therapy has not yet expired]. Schattenkirchner M Z Rheumatol; 1996; 55(5):297-8. PubMed ID: 9036715 [No Abstract] [Full Text] [Related]
44. [Cyclophosphamide in the therapy of rheumatoid arthritis and its complications]. Trefler J; Matyska-Piekarska E; Łacki JK Pol Merkur Lekarski; 2007 Jun; 22(132):566-70. PubMed ID: 17874631 [TBL] [Abstract][Full Text] [Related]
50. The economics of treatment in early rheumatoid arthritis. Bansback N; Marra CA; Finckh A; Anis A Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):83-92. PubMed ID: 19233048 [TBL] [Abstract][Full Text] [Related]
51. Second-line drugs for arthritis: the reasons for early use. Pullar T Practitioner; 1995 Jun; 239(1551):387-90. PubMed ID: 7659660 [No Abstract] [Full Text] [Related]
54. Established rheumatoid arthritis: clinical assessments. van Riel PL; Fransen J Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):807-25. PubMed ID: 17870029 [TBL] [Abstract][Full Text] [Related]
55. Management of established rheumatoid arthritis with an emphasis on pharmacotherapy. Blom M; van Riel PL Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):43-57. PubMed ID: 17350543 [TBL] [Abstract][Full Text] [Related]
56. Another DMARD option in rheumatoid arthritis? Capell HA; Madhok R J Rheumatol; 2003 Oct; 30(10):2085-7. PubMed ID: 14528497 [No Abstract] [Full Text] [Related]
57. Innovative treatment strategies for patients with rheumatoid arthritis. van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520 [TBL] [Abstract][Full Text] [Related]
59. Aggressive therapy in rheumatoid arthritis. Roger L J Rheumatol; 1998 Jan; 25(1):186-7. PubMed ID: 9458229 [No Abstract] [Full Text] [Related]
60. Failure to control progression of rheumatoid arthritis after a decade of biologic therapy. Scheinberg M; Filippi RZ; Hands R; Pitzalis C J Rheumatol; 2012 Oct; 39(10):2049-50. PubMed ID: 23028032 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]